Egypt’s Epilepsy drug market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Epilepsy refers to a chronic neurological disorder that causes constant and unfounded seizures. An individual suffering from epilepsy tends to have seizures with no explanation. These seizures could be caused by some traumatic incident or past brain injury, but the real causes are still unknown.
The condition is generally among children and adults, but the geriatric population is at more risk of acquiring the disease, making Egypt susceptible to the disease.
Epilepsy market has observed considerable development in recent years and is foreseen to encounter tremendous development in the upcoming years due to the rising prevalence of epilepsy. The high neglected therapeutic need will drive the development prospects for the market throughout the estimated time frame. As of 2017, the prevalence of epilepsy in Egypt was 6.98 / 1000.
The condition is generally among children and adults, but the geriatric population is at more risk of acquiring the disease. Egypt’s rising geriatric population and awareness among the people will increase the market share for the treatment of epilepsy in the country.
There is also a rise in the prevalence of neurological disorders due to rising road-traffic accidents and other injuries that are a factor for these. Further, the government is taking several active initiatives with other countries in the middle east. This is also a positive sign for the epilepsy treatment segment.